DK0500953T3 - Potentiator af antineoplastisk virkning og antineoplastisk middel - Google Patents

Potentiator af antineoplastisk virkning og antineoplastisk middel

Info

Publication number
DK0500953T3
DK0500953T3 DK91915614.1T DK91915614T DK0500953T3 DK 0500953 T3 DK0500953 T3 DK 0500953T3 DK 91915614 T DK91915614 T DK 91915614T DK 0500953 T3 DK0500953 T3 DK 0500953T3
Authority
DK
Denmark
Prior art keywords
antineoplastic
potentiating
potentiator
agent
antineoplastic effect
Prior art date
Application number
DK91915614.1T
Other languages
English (en)
Inventor
Junji Uchida
Hiroyuki Okabe
Teiji Takechi
Setsuo Takeda
Yuji Yamada
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17034249&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0500953(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DK0500953T3 publication Critical patent/DK0500953T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Compounds Of Unknown Constitution (AREA)
DK91915614.1T 1990-09-07 1991-09-05 Potentiator af antineoplastisk virkning og antineoplastisk middel DK0500953T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23871990 1990-09-07

Publications (1)

Publication Number Publication Date
DK0500953T3 true DK0500953T3 (da) 1997-01-06

Family

ID=17034249

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91915614.1T DK0500953T3 (da) 1990-09-07 1991-09-05 Potentiator af antineoplastisk virkning og antineoplastisk middel

Country Status (14)

Country Link
EP (1) EP0500953B1 (da)
JP (1) JP2557303B2 (da)
KR (1) KR0146952B1 (da)
AT (1) ATE141506T1 (da)
AU (1) AU644684B2 (da)
CA (1) CA2071819A1 (da)
DE (2) DE69121551T2 (da)
DK (1) DK0500953T3 (da)
ES (1) ES2091941T3 (da)
GR (1) GR3021003T3 (da)
HU (1) HU211739A9 (da)
LU (1) LU90791I2 (da)
NL (1) NL300041I2 (da)
WO (1) WO1992004028A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05310573A (ja) * 1992-05-01 1993-11-22 Dotsuto:Kk リウマチ治療薬
US5643191A (en) * 1995-01-26 1997-07-01 Sorin Biomedical Inc. Cardioplegia delivery system and method for converting from warm cardioplegia to cold cardioplegia
US5702358A (en) * 1995-02-23 1997-12-30 Sorin Biomedical Inc. Cardioplegia delivery apparatus and method of use
US5660835A (en) * 1995-02-24 1997-08-26 East Carolina University Method of treating adenosine depletion
RU2198171C2 (ru) * 1998-10-12 2003-02-10 Леонидов Николай Борисович Новая кристаллическая модификация 5-фтор-1-(тетрагидро-2-фурил)-урацила и комплексные соединения на ее основе, обладающие противоопухолевым действием
DK1604991T3 (da) * 2003-03-14 2009-01-05 Taiho Pharmaceutical Co Ltd Antitumorvirkningsforstærker og antitumormiddel
TWI468188B (zh) 2008-01-30 2015-01-11 Univ Tokushima Anti-cancer effect enhancers consisting of oxaliplatin liposomal preparations and anticancer agents comprising the formulation
WO2009139085A1 (ja) 2008-05-12 2009-11-19 静岡県 抗腫瘍剤、キット及び癌治療方法
KR102258514B1 (ko) * 2019-09-23 2021-05-31 연세대학교 산학협력단 신규한 다층형 좌약 제제

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5953885B2 (ja) * 1978-02-10 1984-12-27 大鵬薬品工業株式会社 抗腫瘍剤組成物
GB2016921B (en) * 1978-03-27 1982-08-18 Taiho Pharmaceutical Co Ltd Anti cancer compositions containing uracil derivatives
JPS5780319A (en) * 1980-11-06 1982-05-19 Taiho Yakuhin Kogyo Kk Anti-tumor agent having reduced toxicity
JPS5838210A (ja) * 1981-08-31 1983-03-05 Taiho Yakuhin Kogyo Kk 直腸投与用製剤

Also Published As

Publication number Publication date
ES2091941T3 (es) 1996-11-16
ATE141506T1 (de) 1996-09-15
EP0500953B1 (en) 1996-08-21
AU8447991A (en) 1992-03-30
EP0500953A4 (en) 1993-04-21
EP0500953A1 (en) 1992-09-02
HU211739A9 (en) 1995-12-28
DE69121551D1 (de) 1996-09-26
KR0146952B1 (ko) 1998-08-17
DE10299023I1 (de) 2003-06-05
NL300041I1 (nl) 2001-06-01
NL300041I2 (nl) 2002-02-01
JP2557303B2 (ja) 1996-11-27
CA2071819A1 (en) 1992-03-08
DE10299023I2 (de) 2010-05-06
AU644684B2 (en) 1993-12-16
LU90791I2 (fr) 2001-10-08
KR927002224A (ko) 1992-09-03
GR3021003T3 (en) 1996-12-31
DE69121551T2 (de) 1997-01-02
WO1992004028A1 (fr) 1992-03-19

Similar Documents

Publication Publication Date Title
DE69318031T2 (de) Ematiomerenreine beta-d-dioxolane nucleoside mit selektiver antihepatitis b-virus wirkung
FI862011A (fi) Terapeutiska nukleosider.
LU90334I2 (fr) Raloxifene et ses sels et dérivés pharmaceutiquement acceptables
NL970006I2 (nl) Gebruik van indolon-derivaten voor het bereiden van geneesmiddelen ter behandeling van de ziekte vanParkinson.
MX9707453A (es) Derivados de quinazolina.
ATE108657T1 (de) Galanthemin enthaltende pharmazeutische formulierung zur behandlung des alkoholismus.
PT97785A (pt) Metodo para a tratamento da impotencia utilizando, por exemplo, doxazosina
DK0768086T3 (da) Behandling af tinnitus med neurobeskyttende virksomme stoffer
SE8801729D0 (sv) Purine derivatives for use in therapy
TR199802060T2 (xx) Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�.
DK324185D0 (da) 2-substituerede 1,3-propylidendiphosphonatderivater, deres fremstilling og farmaceutiske praeparater med indhold deraf
DK0500953T3 (da) Potentiator af antineoplastisk virkning og antineoplastisk middel
DE3875769D1 (de) Therapeutische nukleoside.
ATE159258T1 (de) 4-desoxy-4-epipodophyllotoxinderivate oder deren pharmazeutisch akzeptierbaren salze
ATE147625T1 (de) Hydantoin- oder imidazolidintrionderivate zur vorbeugung oder behandlung von niereninsuffizienz
FI934680A0 (fi) Arylmorfolin, framstaellning och anvaending
BG100599A (en) Antiviral form and therapeutical method
MC1930A1 (fr) Produit antiviral
IL97054A0 (en) Pharmaceutical compositions comprising buspirones for the treatment of sleep apneas
DK0590355T3 (da) Anvendelse af L-carnitin og acyl-L-carnitiner til behandling af patienter, der lider af AIDS-relaterede syndromer og asymptomatiske HIV-seropositive patienter
TR200102009T2 (tr) Serebral işlemi profilaksı ve tedavisi için formül I'e göre bileşiklerin kullanımı
WO1990006116A3 (de) Mittel zur behandlung von chronisch entzündlichen darmerkrankungen
PT728002E (pt) Utilizacao de derivados de 2-amino purina para o tratamento e profilaxia da infeccao pelo virus de herpes 7 humano
DK0445894T3 (da) Anvendelse af tumornekrosefaktor